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Evidence supporting the functionality of Smoothened (SMO),
an essential transducer in most pathways engaged by Hedgehog
(Hh), as a Gi-coupled receptor contrasts with the lack of an
apparently consistent requirement for Gi inHh signal transduc-
tion. In the present study, we sought to evaluate the role of
SMO-Gi coupling in fibroblast migration induced by Sonic
Hedgehog (Shh). Our results demonstrate an absolute
requirement for Gi in Shh-induced fibroblast migration. We
found that Shh acutely stimulates the small Rho GTPases
Rac1 and RhoA via SMO through a Gi protein- and PI3K-de-
pendent mechanism, and that these are required for cell
migration. These responses were independent of transcrip-
tion by Gli and of the C-terminal domain of SMO, as we show
using a combination of molecular and genetic tools. Our find-
ings provide a mechanistic model for fibroblast migration in
response to Shh and underscore the role of SMO-Gi coupling in
non-canonical Hh signaling.
Concerted cell proliferation, migration and differentiation in
response to Hedgehog (Hh) proteins are required for normal
embryonic development and postnatal homeostasis (1). Lack of
Hh signaling is embryonic lethal, whereas hyperactivation of
the Hh pathway underlies oncogenic transformation and pro-
motes tumor maintenance in a large spectrum of human can-
cers, including basal cell carcinoma of the skin, medulloblas-
toma, rhabdomyosarcoma, some forms of leukemia, and
gastric, pancreatic, biliary tract, breast, prostate, and lung ade-
nocarcinomas (2–5). A role for Hh signaling has been reported
in metastasis (6–8).
TheHh family of secreted proteins, Sonic (Shh), Indian (Ihh),
and Desert Hedgehog (Dhh), exerts its functions by binding to
the 12-transmembrane (12-TM)3 receptor Patched1 (Ptc1)
and, in a restricted cell population, Patched2 (Ptc2). Binding of
Hh proteins to Ptc1 results in derepression of the 7-TMprotein
Smoothened (SMO). Ptc1 is thought to inhibit the activity
of SMO by preventing its accumulation in the primary cilium, a
single immotile flagellar-like structure derived from the centro-
some present inmost cells during interphase and after cell cycle
exit (9, 10). Translocation of SMO to the primary cilium by
lateral diffusion from the plasma membrane in response to Hh
is presumed to cause a conformational change resulting in
stimulation of transcription by the Gli family of transcription
factors (Gli1, Gli2, and Gli3) (11–13).
We demonstrated recently that SMO has the capacity to sig-
nal through heterotrimeric G proteins (14). We showed, using
[35S]GTPS binding, that SMO can activate all members of the
Gi family of G proteins and was highly selective in this regard.
This property is required, in NIH 3T3 cells, for activation of
Gli-dependent transcription by Shh as it is blocked by a Borde-
tella pertussis toxin (PTX) (14), which uncouples most mem-
bers of the Gi family from 7-TM receptors. Whether Gi is
required in all cell types for activation of Gli transcription fac-
tors, however, is unlikely given the paucity of data regarding
PTX in this context. Expression of PTX in the developing neu-
ral tube failed to perturb the classical morphogenetic function
of Shh (15); for example, in this instance, as neural progenitors
express Gz, a PTX-resistant form of Gi, it is conceivable that Gz
compensates for the inhibition of other Gi family isoforms.
Although the best characterized cellular responses to Hh
involve Gli-dependent transcription and occur over the course
of hours if not days, many cell types respond to Hh in a seem-
ingly Gli-independent fashion (16). Examples of the so called
“non-canonical” Hh signaling are fibroblast migration, endo-
thelial cell tubulogenesis, and axon growth cone repulsion, all of
which are underlined by cytoskeletal changes (17–19). Fibro-
blasts deficient in Gli2 and Gli3 migrate in response to Shh
indistinguishably from wild type counterparts (17). Although
these cells still express very low levels of Gli1, the absence of an
effect ofGli2/Gli3 deficiency and the time frameof the response
suggest that Shh-induced cell migration is independent of Gli
transcriptional activity.
We demonstrated previously in human endothelial cells that
Hh isoforms are capable of stimulating the monomeric G pro-
tein RhoA in a Gi-dependentmanner (18). In the present study,
we sought to investigate the mechanistic basis underlying Shh-
induced fibroblast migration, in particular to establish the role
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Supplemental Material can be found at:
of coupling of SMO to Gi in this paradigm. Our results reveal a
strict requirement for Gi and PI3K in Shh-induced fibroblast
migration, which is mediated by the rapid stimulation of Rac1
and RhoA small GTPases. We show as well that activation of
the monomeric GTPases by SMO does not require Gli tran-
scriptional activity nor any other signal encoded by the cyto-
plasmic C-terminal tail of SMO. These results suggest that
SMO initiates canonical and non-canonical responses to Hh
stimulation via separate domains and that Gi proteins play a
central role in non-canonical signaling by linking Hh signaling
to small Rho GTPases.
EXPERIMENTAL PROCEDURES
Reagents—KAAD-cyclopamine, purmorphamine, and
LY294002 were from EMDBiosciences (Madison,WI). Pertus-
sis toxin was purchased from Sigma-Aldrich. Anti-RhoA
(67B9) rabbit mAb was obtained from Cell Signaling Technol-
ogy (Danvers, MA), anti-Rac mouse clone 23A8 Ab from Mil-
lipore (Billerica, MA), and anti-SMO E5 mAb was purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Secondary
anti-rabbit-HRP and anti-mouse-HRP antibodies were from
Santa Cruz Biotechnology, and rhodamine-phalloidin was pur-
chased from Molecular Probes (Eugene, OR). DMEM and FBS
were from Mediatech, Inc. (Waltham, MA), and newborn calf
serum was from Invitrogen.
Plasmids and Adenoviral Vectors—Mouse SMO-M2 (ob-
tained from P. Beachy, Stanford University) was subcloned into
the pcDNA3.1 vector. A C-terminal deletion, SMO-M2
(1–551), was created by PCR amplification and recloning.
SMO-M2-CLD (W549A,R550A) was constructed by site-di-
rected mutagenesis of full-length SMO-M2 plasmid using the
QuikChange kit (Agilent Technologies, Santa Clara, CA). The
vector series pAX142, pAX142-RhoN19, and pAX142-RacN17
were a generous gift of Dr. Andrew Aplin (Thomas Jefferson
University). All other plasmids were described previously (14).
GFP AdV particles were a gift of Dr. Wally Koch (Thomas
Jefferson University). Gli3R-GFP AdV was generated by
homologous recombination of pShuttle-Gli3R-GFP (a gener-
ous gift of Dr. Bradley Yoder, University of Alabama) with the
AdV backbone following the Adeno-X kit’s directions (Clon-
tech, Mountain View, CA). AdV particles were amplified in
AD-293 cells, and the titer was determined using the AdEasy
Viral Titer kit (Agilent Technologies, Santa Clara, CA).
Synthesis and Purification of Hedgehog Proteins—Recombi-
nant Shh ligand was synthesized and purified as described pre-
viously (20). Briefly, Shh was synthesized as CBP-fusion pro-
teins in Escherichia coli, purified using a calmodulin-affinity
column with elution achieved by calcium. The purified fusion
protein (inactive) was then cleaved at a single enterokinase site
to release the intact (active) protein, which was then separated
from the CBP peptide and cleaned from endotoxin contamina-
tion using Detoxi-Gel purification columns (Pierce). The spe-
cific activity was estimated by ability to induce a Gli-luciferase
reporter in Light II fibroblasts in comparison with 5 M pur-
morphamine (20).
Cell Culture—NIH 3T3 cells and Smo/mouse embryonic
fibroblasts (MEFs) (from Dr. James Chen, Stanford University)
were cultured in DMEM supplemented with 10% FBS and 100
units/ml penicillin-streptomycin. Ptc1/ and Ptc1/ MEFs
(fromDr.Matthew Scott, StanfordUniversity) were cultured in
DMEM with 10% newborn calf serum and 100 units/ml peni-
cillin-streptomycin. All cells were maintained in a humidified
37 °C incubator at 5% CO2.
For the rescue experiments in SMO/ MEFs, cells were
transfected with pcDNA, SmoM2, SmoM2-C, or SmoM2-
CLD plasmids using Fugene HD (Roche Diagnostic). Stably
transfected cells were selected with 75 g/ml geneticin.
Rac and Rho Pulldown Assays—The cellular levels of GTP-
loaded (active) Rac1 and RhoA were determined using a GST
fusion protein containing the p21-binding domain of p21-acti-
vated kinase and the Rho binding domain of rhotekin, respec-
tively (21, 22). Briefly, NIH 3T3, Ptc1/, and Ptc1/ fibro-
blasts were plated on 5-cm culture dishes and, prior to attaining
confluence, were starved 16 h. The cells were then incubated
with Shh (5 min for Rac1 and 15 min for RhoA) and lysed in 25
mM HEPES, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 10 mM
MgCl2, 1 mM EDTA, and 2% glycerol, and the lysate was clari-
fied by centrifugation at 12,000 g for 10min. A portion of the
supernatant aliquotwas retained formeasurement of total Rac1
and RhoA, whereas the remaining supernatant was incubated
for 1 h at 4 °C with p21-binding domain-GST or Rho binding
domain of rhotekin-GST bound to GSH-Sepharose 4B beads
(GE Healthcare). Beads were washed three times, and bound
proteins were eluted with Laemmli buffer, separated in 12%
SDS-polyacrylamide gels (Mini Protean II System, Bio-Rad),
and transferred onto nitrocellulose membranes. For RhoA
detection, membranes were blocked in 5% bovine serum albu-
min-TBST (20 mM Tris, 150 mMNaCl, pH 7.5, containing 0.1%
Tween 20), washed three times with TBST, and incubated with
anti-RhoA (67B9) rabbit mAb antibody (1:1000) overnight at
4 °C. For Rac1 detection, membranes were blocked in PBS con-
taining 3% nonfat dry milk at room temperature for 1 h, fol-
lowed by five washes with mQ water and overnight incubation
with anti-Rac1 23A8 mAb (1:1000) at 4 °C. After three washes
with TBST for RhoA and five washes with mQ water for Rac1,
the membranes were incubated with HRP-conjugated second-
ary antibodies at room temperature for 2 h. After extensive
washing, the membranes were developed using the Western
Lightning-ECL reagent (PerkinElmer Life Sciences). Band
intensities were quantified using the free NIH ImageJ software.
Densitometric values were first normalized to total RhoA or
total Rac1 levels and then expressed as fold differences over the
control treatment.When inhibitors were used, theywere added
45 min before Shh or purmorphamine treatment except for
PTX, which was added overnight prior to treatment.
Semi-quantitative RT-PCR—Total RNA was isolated from
cells using the RNeasy kit (Qiagen, Valencia, CA) as directed.
cDNAwas synthesized from2g RNAusing the SuperScriptIII
System (Invitrogen) with hexa-random primers following the
protocol provided by the manufacturer. One l of cDNA were
used for PCR using the following sequence-specific primers:
Gli1-F, 5-GGA CCTGCA GAC GGT TAT CC; Gli1-R,
5-AGC CTC CTGGAGATGTGCAT; Ptc1-F, 5-CGA TGG
AGT CCT TGCCTA CAA; Ptc1-R, 5-CCA CCA GAC GCT
GTT TAG TCA; S15-F, 5-TTC CGC AAGTTC ACC TAC C;
and S15-R, 5-CGG GCC GGC CAT GCTTTA CG.
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Wound Healing Assays—The cells were seeded in 12-well
plates (pre-coated with 2% gelatin) and cultured in complete
medium until confluent. At that point, medium were replaced
by DMEM containing 0.5% FBS for 24 h. Inhibitors or vehicles
were added during the last 12 h (PTX, 100 ng/ml) or 45min (15
M LY294002 or 0.5MKAAD-CP) before t 0. At t 0, cells
were washed once with PBS, and a scratch was made with an
Eppendorf P20 pipette tip. PBS was replaced immediately with
DMEM containing 0.5% FBS without or with purified Shh (2.5
g/ml) or purmorphamine (5 M) with or without inhibitors.
Pictures of four zones along the scratch were taken at t  0 h
and t 8 h using a Nikon Eclipse TS100 inverted microscope.
For each sample, five distance measurements (in m) were
taken at evenly spaced points along the scratch at t 0h and t
8 h, and cellmigrationwas expressed as the (mean t 8mean
t 0) for each sample. Results were expressed as m in 8 h or
percentage relative to the control group.
Statistics—Experiments comparing two groups were ana-
lyzed by a paired Student’s t test. Those experiments involving
comparison of three or more groups were analyzed by one-way
analysis of variance, followed by Tukey’s multiple comparisons
test using GraphPad Prism (version 5.0).
RESULTS
Sonic Hedgehog Promotes Fibroblast Migration in a Smooth-
ened-dependent Manner—To determine whether the coupling
of SMO to one or more members of the Gi family has a role in
fibroblast migration, we wanted to first establish whether cell
migration induced by Shh is strictly dependent on SMO, as
other routes of Shh signaling exist (16, 18). To this end, we
compared the effect of Shh with that of purmorphamine, a
direct SMO agonist, on migration. We used two cell lines to
confirm the results, immortalized Ptc1/MEFs and NIH 3T3
fibroblasts. The first, which were used as a matter of conven-
ience, behave and respond similar to wild-type MEFs to Shh
(Ref. 23 and see below). Both Shh and purmorphamine stimu-
lated migration of the cells 2–2.5-fold as determined by
scratch-wound healing assays (Fig. 1, A and B, and supplemen-
tal Fig. S1, black bars). The response to the two agonists is
comparable with other promigratory stimuli for fibroblasts, for
example PDGF-BB (24). Pretreatment of cells with an inverse
agonist specific for SMO, KAAD-cyclopamine, which prevents
activation of Gli-dependent transcription as well as stimulation
of Gi proteins by SMO (14), completely blocked cell migration
in response to both agonists (Fig. 1, A and B, and supplemental
Fig. S1, white bars). The basal rate of migration was similar in
KAAD-cyclopamine- and vehicle (DMSO)-treated cells. These
data, obtained with immortalized fibroblasts, demonstrate that
Shh- and purmorphamine-elicited migration requires SMO.
We also extended the studies to primary MEFs. Complete
Ptc1 deficiency results in de-repressed constitutive activation
of SMO and embryonic lethality between 9.5–10 days post
coitum (25). Thus, we compared the basal migration rate of
MEFs isolated from Ptc1/ 8.5 days post coitum embryos and
from their Ptc1/ littermates. Spontaneous wound closure by
Ptc1/MEFs was faster than that by Ptc1/ cells, and addi-
tion of KAAD-cyclopamine reduced the migration rate to that
of Ptc1/ cells (Fig. 1, C and D), indicating that the faster rate
is entirely attributable to constitutive SMO activation. The
motility of MEFs deficient in SMO (SMO/ MEFs, Fig. 1, E
and F) was, as expected, far less than that of Ptc1/MEFs and
insensitive to purmorphamine and KAAD-cyclopamine mod-
ulation. Altogether, the data confirm that Shh promotes fibro-
blast migration and establish that SMO is necessary and suffi-
cient for this process.
Activation of PI3K/Akt and Gi Is Essential for SMO-induced
Migration—Shh stimulates PI3K and Akt activities in fibro-
blasts and many other cells (26, 27). As shown in Fig. 2A, direct
stimulation of SMOwith purmorphamine increased Akt phos-
phorylation at Ser-473 in Ptc1/MEFs in a manner sensitive
to KAAD-cyclopamine. Akt is often downstream of Gi and
PI3K. To determine whether SMO promotes migration of
fibroblasts via stimulation of Gi and/or PI3K, we pretreated
Ptc1/MEFs with PTX or with LY294002, respectively. Both
inhibitors completely blocked purmorphamine-stimulated
migration (Fig. 2B).
We evaluated Ptc1/ and SMO/ MEFs as well. In
Ptc1/ MEFs, basal phosphorylation level of PDK-1 and Akt
in the absence of serum was sensitive to inhibition by KAAD-
FIGURE 1. Shh promotes fibroblast migration through SMO. A, migration
of Ptc1/mouse embryonic fibroblasts during 8 h after scratching a mono-
layer in the absence of serum. Vehicle (control) or 2.5g/ml Shh were added
at t 0 h. Photographs are representative of n 6 experiments. B, quantifi-
cation of Ptc1/ migration without any stimulus (control), 2.5 g/ml Shh
(Shh), or 5Mpurmorphamine (PUR). Cells were pretreatedwithDMSO (black
bars) or 0.5M KAAD-cyclopamine (KAAD) (white bars) (n 6; *, p 0.001). C,
comparison of spontaneous migration of Ptc1/ and Ptc1/ MEFs in the
absence or presence of 0.5 M KAAD. D, quantification of basal Ptc1/ and
Ptc1/MEFsmigration, the latter in the absence or presence of 0.5MKAAD
(n  6; *, p  0.023). Representative images (E) and quantification (F) of
wound healing assays using SMO/ MEFs treated with 5 M purmor-
phamine or 0.5 M KAAD (n 6).
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cyclopamine and PTX (Fig. 2C). These data suggest that uncon-
strained activation of SMO in the absence of Ptc1 is able to
maintain PI3K/Akt activation in a Gi-dependent manner. In
SMO/ MEFs, PDK-1 and Akt phosphorylation was not
affected by KAAD-cyclopamine or PTX (Fig. 2D), as was the
case in Ptc1/ cells in the absence of Hh stimulation (Fig. 2E).
Basal migration of Ptc1/ MEFs was reduced by PTX and
LY294002 (Fig. 2F, gray bars), comparable with the inhibitory
effect of KAAD-cyclopamine. In contrast, SMO/ MEFs
migrated at a similar rate in the presence of vehicle, PTX, or
LY294002 (Fig. 2F, black bars). These data confirm that the
Gi/PI3K/Akt axis operates downstream of SMO to promote
fibroblast migration.
Sonic Hedgehog Stimulates Small GTPases Rac1 and RhoA—
Cell migration requires the coordinated activation of Rac and
Rho, members of the Rho family of small GTPases. Shh might
therefore regulate actin cytoskeleton dynamics through mem-
bers of this family. To determine whether this is the case, we
performed pulldown assays in NIH 3T3 cells stimulated with
Shh. As shown in Fig. 3, A and B, Shh induced a biphasic acti-
vation of Rac1, with an early peak at 5min and a later increase at
15 min. Shh also stimulated RhoA with a maximal effect
between 5 and 10min, which later led to a decline (Fig. 3,C and
D). Moreover, migration of NIH 3T3 cells was dependent
strictly on coordinated activation of Rac and Rho GTPases
because expression of dominant negative RhoN19 or dominant
negative RacN17 abrogated cell motility (Fig. 3, E and F). Expo-
sure of Ptc1/ MEFs to Shh also led to strong activation of
both RhoA and Rac1 (Fig. 4), suggesting that this was not an
exclusive feature of NIH 3T3 fibroblasts. Next, we reasoned
that if Shh stimulates Rac1 and RhoA activity in a SMO-depen-
FIGURE2.SMO-dependentmigration requiresGi andPI3K signaling.A, serum-starvedPtc1
/MEFswere stimulated for 15minwith 5Mpurmorphamine
(PUR) or vehicle (control) in the absence or presence of 0.5 M KAAD-cyclopamine. Whole cell lysates were separated by SDS-PAGE and blotted for P-Akt
(Ser-473) and total Akt. Densitometry values of P-Akt (Ser-473) normalized to total Akt represent the mean S.E. of three experiments. *, p 0.05. B, quanti-
fication of wound healing assays of Ptc1/MEFs pretreated with 100 ng/ml pertussis toxin or 15 M LY294002 and stimulated with 5 M purmorphamine or
vehicle (DMSO) (n 6; *, p 0.001) C–E, representative experiment of P-Akt (Ser-473) and P-PDK1 (Ser-241) levels in serum-starved Ptc1/MEFs (C), SMO/
MEFs (D), and Ptc1/MEFs (E) treated overnight with 100 ng/ml PTX or 0.5M KAAD-cyclopamine (KAAD) (n 3). F, migration of Ptc1/MEFs (gray bars) or
SMO/MEFs (black bars) in scratch-wound healing assays (t 8 h) preincubatedwith 0.5M KAAD-cyclopamine (KAAD), 100 ng/ml PTX, or 15M LY294002
(LY). (n 4–6; *, p 0.05; ¶, p 0.01).
FIGURE 3. Shh stimulates RhoA and Rac1 small GTPases. A, representative
Rac1 pulldown assay of serum-starved NIH 3T3 cells stimulated for 0–15min
with 2.5g/ml Shh. B, densitometry values of three independent time course
Rac1 pulldown experiments. *, p  0.05. C, representative RhoA pulldown
assay of serum starved NIH 3T3 cells stimulated for 0–15 min with 2.5 g/ml
Shh. D, densitometry values of three independent time-course RhoA pull-
down experiments; *, p 0.05; ¶, p 0.01. E, quantification ofwoundhealing
assays of NIH 3T3 cells co-transfected with GFP and pAX142 (empty vector),
pAX142-RhoN19, or pAX142-RacN17 and stimulated at t 0 with 2.5 g/ml
Shh or vehicle. Values represent the fold increase of GFP cells that migrate
into the wound. *, p  0.05. F, representative images of migration of cells
expressingpAX142, pAX142-RhoN19, or pAX142-RacN17after 8h in thepres-
ence of Shh. Thewhite line shows the scratch border at t 0. Note that green
cells expressingpAX142-RhoN19or pAX142-RacN17 are incapable ofmoving
into the wound.
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dentmanner, the high SMOactivity in Ptc1/MEFs should be
reflected in a high constitutive activation of those small
GTPases. Indeed, Ptc1/MEFs showed an already high level
of GTP-RhoA and GTP-Rac1 (Fig. 4), comparable with or
higher than the Ptc1/ cells stimulated with Shh. This
increase in RhoA and Rac1 activity in Ptc1/MEFs is depen-
dent on SMObecause it was completely reduced to normal levels
by pretreatment of the cells with KAAD-cyclopamine.
Because migration induced by Shh requires Gi and PI3K, we
examined whether activation of Rac1 and RhoA is mediated by
the samepathway. Pretreatment ofNIH3T3 cellswith PTXand
LY294002 blocked RhoA activation to a similar extent that
KAAD-cyclopamine (Fig. 5, A and C). Shh stimulated Rac1-
GTP loading was equally sensitive to LY294002, PTX, and
KAAD-cyclopamine (Fig. 5, B and D).
Lastly, we evaluated whether activation of RhoA and Rac1 by
Gi and PI3K are independent events or whether the activation
of Rac is necessary for that of Rho. For this purpose, Ptc1/
MEFs were transduced with a control GFP AdV or a dominant
negative mutant RacN17 AdV at anMOI of 150 and, after 24 h,
the cells were placed in serum-free medium. Addition of Shh
elicited a robust activation of RhoA in GFP AdV-infected cells
but an	50% lower activation in RacN17-expressing cells (Fig.
6A), which correlates with an approximate 50% viral infection
efficiency. In contrast, introduction of dominant negative Rho
mutant (RhoN19) in Ptc1/MEFs did not perturb Rac1 acti-
vation when compared with GFP-expressing cells (Fig. 6B).
These results suggest that the Shh-mediated activation of RhoA
is at least partly dependent on Rac activity. Altogether, these
findings reveal a novel mechanism linking SMO to small
GTPases of the Rho family in fibroblasts, which is mediated by
one or more members of the heterotrimeric Gi family and by
PI3K.
Requirement for Gi Proteins Is Unrelated to Gli Transcrip-
tional Activity—We reported previously that Gi is necessary for
activation of Gli by Shh and by amutant activated SMO inNIH
3T3 cells (14). Although the activation of Rac1 and RhoA by
Shh seems too rapid to be a consequence of a transcriptional
event, we wanted to rule out that PTX was inhibiting small
GTPase activation by impairing Gli transcriptional activity. In
contrast to our findings in NIH 3T3 cells, induction of the Gli
target genes gli1 and ptc1 in Ptc1/MEFs in response to Shh
or purmorphamine was not affected at all by treatment with
PTX, as determined by RT-PCR or real-time PCR (Fig. 7,A and
B). As a control, KAAD-cyclopamine completely prevented gli1
and ptc1 induction, and LY294002 had a significant inhibitory
effect as well, as we described previously (26). The same was
observed in primaryMEFs (data not shown).Moreover, expres-
sion of gli1 in unstimulated Ptc1/MEFs was high, consistent
with constitutive SMO activity, and was also insensitive to PTX
but sensitive to KAAD-cyclopamine and LY294002 (Fig. 7C).
SMO/ MEFs were used as a control for basal SMO-depen-
dent gli1 expression (Fig. 7C).
Because the insensitivity of Gli activation to PTX in MEFs
was unexpected, we considered the possibility that they express
FIGURE 4. Constitutive activation of SMO in Ptc1/MEFs leads to high
basal RhoA and Rac1 activity. A, Ptc1/ cells were serum-starved for 24 h
and stimulated with 2.5 g/ml Shh or vehicle for 10 min. Ptc1/MEFs were
serum-starved for 24 h and incubated during the last 45 min with vehicle or
0.5MKAAD-cyclopamine. Thebasal and stimulated levels ofGTP-RhoAwere
determined by pulldown assays as described under “Experimental Proce-
dures.” B, GTP-Rac1 levels were evaluated by pulldown assays in conditions
identical to A. Quantification of fractional RhoA (C) and Rac1 (D) GTP loading
by densitometry (n 3; *, p 0.05).
FIGURE 5. Shh stimulates RhoA and Rac1 in a SMO-, Gi-, and PI3K-depen-
dent manner. A, representative RhoA pulldown assay of serum starved NIH
3T3 cells stimulated for 10 min with 2.5 g/ml Shh and pretreated with vehi-
cle, 100 ng/ml PTX, 0.5 M KAAD-cyclopamine (KAAD), or with 15 M
LY294002. B, representative Rac1 pulldown assay of serum-starved NIH 3T3
cells stimulated for 5 min with 2.5 g/ml Shh and pretreated as in A. C, den-
sitometry values of three independent RhoA pulldown experiments. *, p 
0.001. D, densitometry values of three independent Rac1 pulldown experi-
ments. *, p 0.05.
FIGURE6.Rac1activity is required for full RhoAactivationbyShh.A, RhoA
pulldown assay of Ptc1/ MEFs transduced with control GFP-AdV or Myc-
RacN17-AdV (MOI 150) and stimulated with 2.5g/ml Shh or vehicle (con-
trol). Densitometry values of a representative experiment are shown below
the gel. In the bottom gel, expression of RacN17 was confirmed by Western
blot. B, Rac1 pulldown assay of Ptc1/ MEFs transduced with control GFP-
AdV or HA-RhoN19-AdV (MOI  150) and stimulated with 2.5 g/ml Shh or
vehicle.Densitometry valuesof a representative experiment are shownbelow
the gel. Expression of RhoN19 was confirmed byWestern blot to the epitope
tag (bottom gel).
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significant levels of Gz. PTX catalyzes the ADP-ribosylation of
the G subunits of all Gi family members with the exception of
Gz. However, Gz was barely, if at all, detectable in MEFs by
Western blot of total membrane fractions (Fig. 7D). The very
low levels of Gz plus the almost complete sensitivity of events
underlying migration to PTX as a control for the efficacy of the
toxin attest to the fact that Gi function is not required for the
activation of Gli in MEFs.
To more firmly establish that migration and activation of
Rho and Rac by Shh is independent of the canonical (Gli) path-
way in MEFs, we inhibited Gli-mediated transcription with a
GFP fusion of Gli3R, which competes at the promoter regions
for Gli-binding sites and acts as a strong repressor of Gli tran-
scription (28). Ptc1/ MEFs were infected with Gli3R-GFP
AdV or GFP AdV (control), serum-starved overnight, and
exposed the following day to vehicle or purmorphamine for 5
min. Rac pulldown assays showed that neither expression of
Gli3R-GFP nor GFP alone impaired Rac activation by purmor-
phamine (Fig. 8, A and B). In addition, expression of Gli3R did
not perturb Shh-induced fibroblast migration (Fig. 8, C andD).
These data confirm that the rapid effects of Shh on cell motility
through engagement of small GTPases are independent of Gli
transcriptional activity.
SMOVariants RescueActivation of Rac andRho in SMO-null
Fibroblasts Irrespectively of Canonical Hh Pathway—For acti-
vation of the canonical, Gli-dependent pathway, SMO under-
goes translocation to the primary cilium of cells, a single organ-
elle transiently formed during interphase by both lateral plasma
membrane diffusion and by fusion of intracellular SMO-con-
taining vesicles. Translocation of SMO is promoted by purmor-
phamine and other SMO synthetic agonists and is prevented by
Ptc1. Ciliary localization of SMO requires a two-residue motif
at the beginning of the intracellular C-terminal tail. The C-ter-
minal tail is an essential domain for -arrestin recruitment and
interaction with Suppressor of Fused, both prerequisites for Gli
activation, but is dispensable for coupling to heterotrimeric Gi
proteins (14, 29, 30). To evaluate whether migration of fibro-
blasts and activation of the small GTPases Rac1 and RhoA in
response to Shh are independent of the canonical Hh pathway,
we introduced different SMO variants into SMO/ MEFs to
evaluatewhich domain of SMOcan rescue the defects inmigra-
tion and small GTPase activation. We generated stable SMO-
null transfectants harboring empty plasmid, SMO-M2 (W535L),
which is constitutively active toward both Gi and the Gli acti-
vation pathway, SMO-M2-CLD (W535L,W549A,R550A),
which is reported to be ciliary localization-deficient (31), and
SMO-M2-C (SMO-1–551,W535L), which activates Gi but is
unable to activate Gli (14). Using an antibody directed toward
the C-terminal region of SMO (including the seventh trans-
membrane domain), we verified expression of SMO-M2 and
SMO-M2-CLD in geneticin-resistant cells and a weaker
expression of SMO-M2-C (Fig. 9A). Expression of Gli target
genes was restored in MEFs expressing SMO-M2, as expected,
but not in those expressing SMO-M2-C (Fig. 9B). Unexpect-
edly, gli1 expression was also restored in MEFs expressing the
ciliary localization-deficient SMO variant, in apparent contrast
with a recent publication (31). All three SMO-M2 variants, and
most remarkably SMO-M2-C, were able to rescue the activa-
tion of Rac1 andRhoA irrespective of their ability to activate the
canonical pathway (Fig. 8, B andC). Finally, we found that basal
migration rate in wound healing assays was increased signifi-
cantly in SMO/ MEFs stably expressing all three SMO-M2
FIGURE 7. Pertussis toxin does not affect Gli-dependent transcription in
MEFs. A, expression of gli1, ptc1, and the housekeeping gene S15 was ana-
lyzed by semiquantitative RT-PCR. Ptc1/MEFs were grown until fully con-
fluent, pretreated with 100 ng/ml PTX, 0.5 M KAAD-cyclopamine, or 15 M
LY294002 and then stimulated with 2.5g/ml Shh, 5M purmorphamine, or
vehicle for 24 h in DMEMwith 0.5% FBS. B, effect of PTX treatment in Ptc1/
cells was also quantified by real-time PCR. C, effect of PTX, KAAD-cyclo-
pamine, and LY294002 on the basal expression level of gli1 in Ptc1/ and
SMO/ cells.D, expressionofGz inmembranes isolated fromPtc1
/MEFs
or platelets (positive control) by Western blot.
FIGURE 8. SMO-mediatedRac1 activation is independent of Gli transcrip-
tional activity. A, Ptc1/ MEFs were transduced with control GFP-AdV or
Gli3R-GFP-AdV (MOI  150). Following 24 h of serum starvation, cells were
stimulatedwith 5M purmorphamine (PUR) or vehicle (DMSO) for 5min, and
GTP-Rac1 levels were determined by pulldown assays. Expression of the
transgenes was confirmed by Western blot against GFP. B, quantification of
GTP-Rac1 activation by purmorphamine in the presence of Gli3R or GFP (n
3). *, p  0.05. C, quantification of wound healing assays of Ptc1/ MEFs
transduced with GFP-AdV or Gli3R-GFP-AdV and stimulated at t 0 with 2.5
g/ml Shh or vehicle. Values represent the fold increase of GFP cells that
migrate into the wound; *, p 0.05.D, representative images of migration of
cells expressing GFP or Gli3R-GFP after 8 h in the presence of Shh. The white
line shows the scratch border at t 0.
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variants (Fig. 8D). The results with SMO-M2-C demonstrate
again the capacity of SMO to activate events underlying migra-
tion in a fashion independent of Gli.
DISCUSSION
The function of SMO as a G protein-coupled receptor, often
overlooked in view of what many perceive as a G protein-inde-
pendent engagement of Gli transcription factors, is central for
activation of Rho family GTPases by Shh and, consequently, for
Shh-dependent migration of fibroblasts. The present study
underscores a duality in transduction, wherein the activation of
Rho GTPases and stimulation of migration occur through Gi
and are independent of the engagement of Gli. The require-
ment for SMO in the actions of Shh is based on (i) the pro-
migratory actions of purmorphamine, an agonist working
directly on Smo, (ii) enhancedmigration of Ptc/MEFs that is
sensitive to KAAD-cyclopamine, and (iii) impaired migration
in SMO/MEFs. The requirement for Gi is based on sensitiv-
ity of migration to PTX. In this regard, we note that both wild-
type and truncated forms of SMO couple strongly and selec-
tively to this family of G proteins (14). The requirement for
signaling apart from Gli is based on the activity of a SMO
mutant devoid of the C-terminal tail and the inactivity of a
repressor of Gli signaling toward migration.
We extended our previous studies (18) to confirm that not
only is RhoA a target for Smo throughGi, but that the activation
proceeds through Rac1 in a hierarchal fashion and that both of
themonomeric G proteins underlie migration. It has been doc-
umented previously in Swiss 3T3 fibroblasts that microinjec-
tion of a mutant active Rac1V12 stimulates actin polymeriza-
tion with formation of membrane ruffles first, and after 20–30
min induces Rho-dependent formation of stress fibers (32).
Moreover, inhibition of Rac function by expression of domi-
nant negative RacN17 blocks activation of RhoA induced by
several growth factors, including PDGF, EGF, and insulin (32,
33). Our findings that RhoA activation is dependent on Rac1
activity are in line with these observations. Those same growth
factors activate Rac and Rho through a mechanism dependent
on PI3K activity, as assessed by sensitivity to wortmannin (33).
These growth factors act on tyrosine kinase receptors, the ago-
nists used here (Shh and purmorphamine) however act on a
7-TM receptor. In this regard, lysophosphatidic acid and
bombesin, also acting on 7-TM receptors, activate Rac1
through Gi/PI3K (33) and RhoA through G13/RhoGEFs
(reviewed in Ref. 34) in fibroblasts. SMO is unable to couple
directly to G13 (14); thus, the stimulation of RhoA by SMO can
be explained only by a hierarchal Gi/PI3K/Rac1 series of acti-
vations; the activation of RhoA by Rac1 could conceivably be
related to transactivation of a G13-coupled receptor. Despite
the rarity of Gi-mediated activation of RhoA in the literature,
this is not completely unprecedented because stimulation of
muscarinic receptors by carbachol results in Rho activation and
stress fiber formation in a pertussis toxin-sensitive manner (35).
It would seem that Hh signaling diverges at the level of SMO
into transcriptional and non-transcriptional, cytoskeletal path-
ways, akin to signaling achieved by the Frizzled receptors for
Wnt isoforms. InWnt signaling, different pairs of ligand/recep-
tor engage either the canonical -catenin pathway (transcrip-
tional) or the planar polarity (cytoskeletal) pathway in a cell
type-specific fashion (36, 37). Not surprisingly, Frizzled re-
ceptors and SMO are sole members of a subfamily among the G
protein coupled receptor superfamily (38), and Frizzled has also
been shown to couple to theGi protein family, specifically toGo
(39). This unprecedented parallel perhaps exposes a conserva-
tion of functions related by the structure of these atypical G
protein coupled receptors.
The function and localization of SMO is regulated by specific
regions of the protein; a mutant of SMO lacking the C-terminal
tail retains the ability to couple to Gi, indicating that the intra-
cellular loops of SMOmediate interactionwithGi, as is the case
for most G protein coupled receptors (40). Indeed, this mutant
couples more efficiently with Gi2 than the full-length protein
(14), suggesting a partial steric inhibition by the C-terminal tail.
The form of SMO lacking the C-terminal tail is, however,
unable to engage the pathway targetingGli. TheC-terminal tail,
therefore is required for canonical signaling, yet it, too, is insuf-
ficient in this regard (14, 30). Clearly, two or more elements of
SMO structure are relevant to the canonical pathway. In the
case of NIH 3T3 fibroblasts, zebrafish embryos (41) and the
Drosophila wing imaginal disc (42), one of these elements is
coupling to Gi. In some cells, for example MEFs, Gi is not
required.We believe the requirement for Gi as it pertains to Gli
activation can be superceded in some cells by other forms of
signaling perhaps unrelated to SMO.
FIGURE 9. SMO promotes monomeric GTPase activation and cell migra-
tion independently of its capacity to induce gli1. A, upper gels, expression
of SMO variants in membranes prepared from SMO/ MEFs stably trans-
fected with empty pcDNA3.1vector (pcDNA), SMO-M2 (SMO), SMO-M2-CLD
(SMO-CLD), or SMO-M2-C (SMO-C)wasassessedbyWesternblotwith anti-
SMOE5mAb. Full-lengthSMOvariants runat	90kDa,whereas SMO-C runs
at	55 kDa. The asteriskmarks a cross-reactive band. Bottom gels, expression
of gli1 and S15 in the same cell lines was determined by semiquantitative
RT-PCR after 24 h of serum starvation at high cell density. B, densitometry
values of Rac1 activation of the indicated cell lines after 5 min of stimulation
with 5 M purmorphamine (n  3; *, p  0.05; ¶, p  0.01). C, densitometry
values of RhoA activation of the indicated cell lines after 5 min of stimulation
with 5 M purmorphamine (n 3; *, p 0.05). D, purmorphamine-induced
migration (fold compared with DMSO) of SMO/ fibroblasts containing
empty vector or the three SMO-M2 variants (n 3). #, p 0.01; *, p 0.05.
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Our results with SMO lacking the C-terminal tail clearly
indicate that the C-terminal tail is not required for RhoA and
Rac1 activation, as it is not required for heterotrimeric Gi pro-
teins. These results suggest that regulation of the cell motility is
a prototypical non-canonical response to Shh. We also tested
whether a two residue mutation of SMO (W549A,R550A) that
purportedly prevents translocation to the primary cilium, and
therefore cannot activate Gli, could restore a migratory
response to SMO-deficient cells. As expected, the mutation on
a constitutively active SMO background (SMO-M2-CLD) res-
cued the phenotype, but it also induced activation of Gli.We do
not know the reason for the discrepancy in our results in rela-
tion to those published, but we believe that the active confor-
mation of SMO-M2 can perhaps promote ciliary localization
independently of the WR motif, perhaps due to -arrestin2
binding.
In summary, our findings underscore non-canonical signal-
ing of SMO throughGi andmonomericGproteins as an impor-
tant facet of Hh signaling. Our data are limited to migration;
however, a number of events documented for Hh signaling
occur in a time frame that all but precludes transcription as a
basis. These include not only fibroblast migration but also axon
guidance, endothelial tubulogenesis, and reduction of caspase
activation by growth factorwithdrawal (17–19). Towhat extent
any of these are under the control of Gi remains to be docu-
mented. The emerging parallels between SMO and Frizzled
proteins, aswell,may help inform the activities under control of
the non-canonical pathway.
Acknowledgments—We thankMatthew Scott and James Chen (Stan-
ford University), Marcelo Kazanietz (University of Pennsylvania),
Bradley Yoder (University of Alabama), and Andrew Aplin and
Wally Koch (Thomas Jefferson University) for providing us with val-
uable reagents and Feng Shen (University of Pennsylvania) for tech-
nical assistance.
REFERENCES
1. Riobo, N. A., and Manning, D. R. (2007) Biochem. J. 403, 369–379
2. Ruiz i Altaba, A., Sa´nchez, P., andDahmane, N. (2002)Nat. Rev. Cancer. 2,
361–372
3. McMahon, A. P., Ingham, P. W., and Tabin, C. J. (2003) Curr. Top. Dev.
Biol. 53, 1–114
4. Yang, L., Xie, G., Fan, Q., and Xie, J. (2010) Oncogene 29, 469–481
5. Scales, S. J., and de Sauvage, F. J. (2009) Trends Pharmacol. Sci. 30,
303–312
6. Nakamura, K., Sasajima, J., Mizukami, Y., Sugiyama, Y., Yamazaki, M.,
Fujii, R., Kawamoto, T., Koizumi, K., Sato, K., Fujiya,M., Sasaki, K., Tanno,
S., Okumura, T., Shimizu, N., Kawabe, J., Karasaki, H., Kono, T., Ii, M.,
Bardeesy, N., Chung, D. C., and Kohgo, Y. (2010) PLoS One 5, e8824
7. Theunissen, J. W., and de Sauvage, F. J. (2009) Cancer Res. 69, 6007–6010
8. Tian,H., Callahan, C.A., DuPree, K. J., Darbonne,W.C., Ahn,C. P., Scales,
S. J., and de Sauvage, F. J. (2009) Proc. Natl. Acad. Sci. U.S.A. 106,
4254–4259
9. Rohatgi, R., Milenkovic, L., and Scott, M. P. (2007) Science 317, 372–376
10. Seeley, E. S., and Nachury, M. V. (2010) J. Cell Sci. 123, 511–518
11. Milenkovic, L., Scott, M. P., and Rohatgi, R. (2009) J. Cell Biol. 187,
365–374
12. Wang, Y., Zhou, Z., Walsh, C. T., and McMahon, A. P. (2009) Proc. Natl.
Acad. Sci. U.S.A. 106, 2623–2628
13. Kim, J., Kato,M., and Beachy, P. A. (2009)Proc. Natl. Acad. Sci. U.S.A. 106,
21666–21671
14. Riobo, N. A., Saucy, B., Dilizio, C., and Manning, D. R. (2006) Proc. Natl.
Acad. Sci. U.S.A. 103, 12607–12612
15. Low, W. C., Wang, C., Pan, Y., Huang, X. Y., Chen, J. K., and Wang, B.
(2008) Dev. Biol. 321, 188–196
16. Jenkins, D. (2009) Cell Signal 21, 1023–1034
17. Lipinski, R. J., Bijlsma, M. F., Gipp, J. J., Podhaizer, D. J., and Bushman,W.
(2008) BMC Cell Biol. 9, 49
18. Chinchilla, P., Xiao, L., Kazanietz,M.G., andRiobo,N.A. (2010)Cell Cycle
9, 570–579
19. Yam, P. T., Langlois, S. D., Morin, S., and Charron, F. (2009) Neuron 62,
349–362
20. Martinez-Chinchilla, P., and Riobo, N. A. (2008) Methods Enzymol. 446,
189–204
21. Yang, C., Liu, Y., Leskow, F. C.,Weaver, V.M., andKazanietz,M.G. (2005)
J. Biol. Chem. 280, 24363–24370
22. Ren, X. D., and Schwartz, M. A. (2000)Methods Enzymol. 325, 264–272
23. Bailey, E. C., Milenkovic, L., Scott, M. P., Collawn, J. F., and Johnson, R. L.
(2002) J. Biol. Chem. 277, 33632–33640
24. Woodard, A. S., García-Carden˜a, G., Leong, M., Madri, J. A., Sessa, W. C.,
and Languino, L. R. (1998) J. Cell Sci. 111, 469–478
25. Milenkovic, L., Goodrich, L. V., Higgins, K. M., and Scott, M. P. (1999)
Development 126, 4431–4440
26. Riobo´, N. A., Lu, K., Ai, X., Haines, G. M., and Emerson, C. P., Jr. (2006)
Proc. Natl. Acad. Sci. U.S.A. 103, 4505–4510
27. Stecca, B., and Ruiz I Altaba, A. (2010) J. Mol. Cell. Biol. 2, 84–95
28. Meyer, N. P., and Roelink, H. (2003) Dev. Biol. 257, 343–355
29. Chen, W., Ren, X. R., Nelson, C. D., Barak, L. S., Chen, J. K., Beachy, P. A.,
de Sauvage, F., and Lefkowitz, R. J. (2004) Science 306, 2257–2260
30. Varjosalo, M., Li, S. P., and Taipale, J. (2006) Dev. Cell. 10, 177–186
31. Corbit, K. C., Aanstad, P., Singla, V., Norman, A. R., Stainier, D. Y., and
Reiter, J. F. (2005) Nature 437, 1018–1021
32. Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., and Hall, A.
(1992) Cell 70, 401–410
33. Nobes, C. D., Hawkins, P., Stephens, L., and Hall, A. (1995) J. Cell Sci. 108,
225–233
34. Riobo, N. A., and Manning, D. R. (2005) Trends Pharmacol. Sci. 26,
146–154
35. Togashi, H., Emala, C. W., Hall, I. P., and Hirshman, C. A. (1998) Am. J.
Physiol. 274, 803–809
36. Widelitz, R. (2005) Growth Factors 23, 111–116
37. Rao, T. P., and Ku¨hl, M. (2010) Circ. Res. 106, 1798–1806
38. Kristiansen, K. (2004) Pharmacol. Ther. 103, 21–80
39. Katanaev, V. L., Ponzielli, R., Se´me´riva, M., and Tomlinson, A. (2005) Cell
120, 111–122
40. Fanelli, F., De Benedetti, P. G., Raimondi, F., and Seeber, M. (2009) Curr.
Protein Pept. Sci. 10, 173–185
41. Hammerschmidt, M., and McMahon, A. P. (1998) Dev. Biol. 194,
166–171
42. Ogden, S. K., Fei, D. L., Schilling, N. S., Ahmed, Y. F., Hwa, J., and Robbins,
D. J. (2008) Nature 456, 967–970
Smoothened PromotesMigration via Gi Protein Signaling
19596 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 22•JUNE 3, 2011
 at M
onash University (CAUL), on June 3, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
